BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 23872355)

  • 1. Berberine combined with 2-deoxy-d-glucose synergistically enhances cancer cell proliferation inhibition via energy depletion and unfolded protein response disruption.
    Fan LX; Liu CM; Gao AH; Zhou YB; Li J
    Biochim Biophys Acta; 2013 Nov; 1830(11):5175-83. PubMed ID: 23872355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining 2-deoxy-D-glucose with fenofibrate leads to tumor cell death mediated by simultaneous induction of energy and ER stress.
    Liu H; Kurtoglu M; León-Annicchiarico CL; Munoz-Pinedo C; Barredo J; Leclerc G; Merchan J; Liu X; Lampidis TJ
    Oncotarget; 2016 Jun; 7(24):36461-36473. PubMed ID: 27183907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of 2-deoxyglucose-induced growth inhibition to cell death in normoxic tumor cells.
    Liu H; Kurtoglu M; Cao Y; Xi H; Kumar R; Axten JM; Lampidis TJ
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):251-62. PubMed ID: 23700291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined inhibition of glycolysis and AMPK induces synergistic breast cancer cell killing.
    Wu Y; Sarkissyan M; Mcghee E; Lee S; Vadgama JV
    Breast Cancer Res Treat; 2015 Jun; 151(3):529-39. PubMed ID: 25975952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Akt potentiates 2-DG-induced apoptosis via downregulation of UPR in acute lymphoblastic leukemia.
    DeSalvo J; Kuznetsov JN; Du J; Leclerc GM; Leclerc GJ; Lampidis TJ; Barredo JC
    Mol Cancer Res; 2012 Jul; 10(7):969-78. PubMed ID: 22692960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Deoxy-d-glucose Promotes Buforin IIb-Induced Cytotoxicity in Prostate Cancer DU145 Cells and Xenograft Tumors.
    Wanyan Y; Xu X; Liu K; Zhang H; Zhen J; Zhang R; Wen J; Liu P; Chen Y
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33297583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Deoxy-D-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion.
    Xi H; Kurtoglu M; Liu H; Wangpaichitr M; You M; Liu X; Savaraj N; Lampidis TJ
    Cancer Chemother Pharmacol; 2011 Apr; 67(4):899-910. PubMed ID: 20593179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Berberine, a natural compound, suppresses Hedgehog signaling pathway activity and cancer growth.
    Wang J; Peng Y; Liu Y; Yang J; Ding N; Tan W
    BMC Cancer; 2015 Aug; 15():595. PubMed ID: 26296751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergism of ursolic acid derivative US597 with 2-deoxy-D-glucose to preferentially induce tumor cell death by dual-targeting of apoptosis and glycolysis.
    Wang J; Jiang Z; Xiang L; Li Y; Ou M; Yang X; Shao J; Lu Y; Lin L; Chen J; Dai Y; Jia L
    Sci Rep; 2014 May; 4():5006. PubMed ID: 25833312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HHQ-4, a quinoline derivate, preferentially inhibits proliferation of glucose-deprived breast cancer cells as a GRP78 down-regulator.
    Xiao X; Li S; Zhang X; Lu J; Wang W; Zhou S; Zhang J; Wang R; Li A
    Toxicol Appl Pharmacol; 2019 Jun; 373():10-25. PubMed ID: 31022492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine and Cisplatin Exhibit Synergistic Anticancer Effects on Osteosarcoma MG-63 Cells by Inhibiting the MAPK Pathway.
    Gao X; Zhang C; Wang Y; Zhang P; Zhang J; Hong T
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33802664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of the unfolded protein response (UPR) by lead compound selectively suppresses cancer cell growth.
    Huang H; Liu H; Liu C; Fan L; Zhang X; Gao A; Hu X; Zhang K; Cao X; Jiang K; Zhou Y; Hou J; Nan F; Li J
    Cancer Lett; 2015 May; 360(2):257-68. PubMed ID: 25721085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine exerts its antineoplastic effects by reversing the Warburg effect via downregulation of the Akt/mTOR/GLUT1 signaling pathway.
    Guo XH; Jiang SS; Zhang LL; Hu J; Edelbek D; Feng YQ; Yang ZX; Hu PC; Zhong H; Yang GH; Yang F
    Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34643248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting of multiple oncogenic signaling pathways by Hsp90 inhibitor alone or in combination with berberine for treatment of colorectal cancer.
    Su YH; Tang WC; Cheng YW; Sia P; Huang CC; Lee YC; Jiang HY; Wu MH; Lai IL; Lee JW; Lee KH
    Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2261-72. PubMed ID: 25982393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine inhibits proliferation and migration of colorectal cancer cells by downregulation of GRP78.
    Gong C; Hu X; Xu Y; Yang J; Zong L; Wang C; Zhu J; Li Z; Lu D
    Anticancer Drugs; 2020 Feb; 31(2):141-149. PubMed ID: 31743135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the unfolded protein response, induced by 2-deoxyglucose, and hypersensitivity to cisplatin: a mechanistic study employing molecular genomics.
    Gaddameedhi S; Chatterjee S
    J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S61-6. PubMed ID: 20009298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Separate and concurrent use of 2-deoxy-D-glucose and 3-bromopyruvate in pancreatic cancer cells.
    Xiao H; Li S; Zhang D; Liu T; Yu M; Wang F
    Oncol Rep; 2013 Jan; 29(1):329-34. PubMed ID: 23076497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatoprotective effects of berberine on liver fibrosis via activation of AMP-activated protein kinase.
    Li J; Pan Y; Kan M; Xiao X; Wang Y; Guan F; Zhang X; Chen L
    Life Sci; 2014 Mar; 98(1):24-30. PubMed ID: 24412384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of unfolded protein response overcomes Ibrutinib resistance in diffuse large B-cell lymphoma.
    Zhang XT; Hu XB; Wang HL; Kan WJ; Xu L; Wang ZJ; Xiang YQ; Wu WB; Feng B; Li JN; Gao AH; Dong TC; Xia CM; Zhou YB; Li J
    Acta Pharmacol Sin; 2021 May; 42(5):814-823. PubMed ID: 32855532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol augments ER stress and the cytotoxic effects of glycolytic inhibition in neuroblastoma by downregulating Akt in a mechanism independent of SIRT1.
    Graham RM; Hernandez F; Puerta N; De Angulo G; Webster KA; Vanni S
    Exp Mol Med; 2016 Feb; 48(2):e210. PubMed ID: 26891914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.